Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Dr. Reddy's Laboratories falls Wednesday, underperforms competitors
Dr. Reddy's Laboratories Ltd. closed 18.05% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...
Dr Reddy's inks South East Asia commercialisation, licence pacts with China's Bio-Thera for Stelara, Simponi biosimilars
HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and ...
Dr. Nageshwar Reddy on innovation, health, and the road ahead
Dr. Nageshwar Reddy views his Padma Vibhushan as a recognition of India’s progress in gastroenterology and the advancements ...
Bio-Thera, Dr. Reddy's partner for biosimilar expansion in Southeast Asia
With this partnership, they aim to enhance access to affordable treatments for patients suffering from autoimmune diseases ...
Dr Reddy's inks pact with China’s Bio-Thera
Hyderabad: Dr Reddy's Labs (DRL) on Wednesday said its subsidiary, Dr Reddy's Labs SA, entered into commercialisation and ...
Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in US
The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...
Baylor College of Medicine3d
Dr. Pavan Reddy elected 2024 AAAS Fellow
Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been elected to ...
Dr. Reddy's Laboratories falls Tuesday, underperforms competitors
Dr. Reddy's Laboratories Ltd. closed 16.87% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...